BPC-157 is one of the most studied peptides in existence — hundreds of published studies across tissue types. Historically, injection was the standard delivery route because of concerns about GI degradation. But the research on oral delivery for gut-specific applications tells a more nuanced story.
## What Is BPC-157?
BPC-157 (Body Protection Compound 157) is a 15-amino acid synthetic peptide derived from a protein found in gastric juice. The fact that it is derived from a gastric protein is relevant: it evolved in an environment of digestive enzymes, which may explain its relative stability compared to other peptides.
Research spans tendon repair, ligament healing, gut lining integrity, muscle recovery, and neuroprotection. It works through growth factor receptor upregulation (VEGFR2, FGFR), angiogenesis promotion, and nitric oxide system modulation.
## Why Oral Drops for Gut Applications
For gut-targeted applications, oral delivery is not a compromise — it may be preferable. When BPC-157 is taken orally, it contacts intestinal mucosa directly before any systemic absorption occurs. Research in intestinal models shows measurable gut healing effects with oral administration independent of systemic bioavailability.
This is analogous to how many gut medications work: directly on the tissue rather than systemically. The peptide does not need to survive intact systemic absorption if the target is the intestinal wall itself.
## What the Research Shows for Oral BPC-157
Studies in rodent models of IBD, NSAID-induced gut damage, and intestinal fistulas show oral BPC-157 produces significant healing effects on intestinal tissue — including improved mucosal barrier integrity, reduced inflammatory marker infiltration, and accelerated healing of intestinal ulcers.
Direct comparison studies between oral and injected BPC-157 in gut damage models show comparable effectiveness for gut-specific endpoints, with injected BPC-157 showing superior effects on non-gut endpoints (tendon, muscle) as expected.
## Oral Drops vs Capsules
Oral drops have two advantages over capsules for BPC-157:
Mucosal contact time: Holding the drops in the mouth or swallowing slowly provides contact with oral and esophageal mucosa before reaching the stomach — increasing the total surface area exposed to the peptide.
Dose flexibility: A dropper lets you adjust dose precisely, which matters when starting a new compound or following a tapering protocol.
## Who Benefits Most from Oral BPC-157
BPC-157 oral drops are most relevant for people with:
- Gut inflammation or IBD (Crohn's, UC, colitis)
- Intestinal permeability concerns
- NSAID-related gut damage
- General digestive wellness support
For systemic applications (tendon repair, muscle recovery, neuroprotection), injectable delivery remains more effective. Oral drops are the right format specifically for gut-focused use.
## How to Use BPC-157 Drops
Hold the dose under the tongue for 30–60 seconds before swallowing. Take on an empty stomach or at least 30 minutes before meals. Standard research protocols range from daily to twice-daily administration for gut applications.
Refrigerate after opening. Use within 60 days.
This article is for educational and informational purposes only. These statements have not been evaluated by the FDA. Dravixx Wellness products are not intended to diagnose, treat, cure, or prevent any disease.